2019 EAACI过敏原免疫治疗指南:家庭尘螨导致的过敏性哮喘

2019-05-07 欧洲变应性反应与临床免疫学会 Allergy. 2019 May;74(5):855-873.

2019年5月,欧洲变应性反应与临床免疫学会(EAACI)发布了家庭尘螨导致的过敏性哮喘过敏原免疫治疗指南,变应原免疫指南治疗用于治疗过敏性疾病已经有100多年的历史,哮喘的治疗主要依靠皮质类古城和其他方法维持哮喘的控制。本文主要针对家庭尘螨导致的过敏性哮喘的过敏原免疫治疗提供指导建议。

中文标题:

2019 EAACI过敏原免疫治疗指南:家庭尘螨导致的过敏性哮喘

英文标题:

EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.

发布日期:

2019-05-07

简要介绍:

2019年5月,欧洲变应性反应与临床免疫学会(EAACI)发布了家庭尘螨导致的过敏性哮喘过敏原免疫治疗指南,变应原免疫指南治疗用于治疗过敏性疾病已经有100多年的历史,哮喘的治疗主要依靠皮质类古城和其他方法维持哮喘的控制。本文主要针对家庭尘螨导致的过敏性哮喘的过敏原免疫治疗提供指导建议。 

拓展指南:哮喘相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 EAACI过敏原免疫治疗指南:家庭尘螨导致的过敏性哮喘)] GetToolGuiderByIdResponse(projectId=1, id=3e61d1c001e39789, title=2019 EAACI过敏原免疫治疗指南:家庭尘螨导致的过敏性哮喘, enTitle=EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma., guiderFrom=Allergy. 2019 May;74(5):855-873., authorId=null, author=, summary=2019年5月,欧洲变应性反应与临床免疫学会(EAACI)发布了家庭尘螨导致的过敏性哮喘过敏原免疫治疗指南,变应原免疫指南治疗用于治疗过敏性疾病已经有100多年的历史,哮喘的治疗主要依靠皮质类古城和其他方法维持哮喘的控制。本文主要针对家庭尘螨导致的过敏性哮喘的过敏原免疫治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=615, associationName=欧洲变应性反应与临床免疫学会, associationIntro=EAACI是一个集临床医生、科研人员及过敏性疾病专家于一体的协会组织,致力于改善受过敏性疾病困扰的患者健康。该协会目前拥有超过6,800名个人成员及41个欧洲国家社团,是欧洲过敏性疾病所有方面知识的主要来源。, copyright=0, guiderPublishedTime=Tue May 07 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年5月,欧洲变应性反应与临床免疫学会(EAACI)发布了家庭尘螨导致的过敏性哮喘过敏原免疫治疗指南,变应原免疫指南治疗用于治疗过敏性疾病已经有100多年的历史,哮喘的治疗主要依靠皮质类古城和其他方法维持哮喘的控制。本文主要针对家庭尘螨导致的过敏性哮喘的过敏原免疫治疗提供指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>哮喘</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=fba6f1c001e33521" title="2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版)" target=_blank>2019 GINA指南:成人和青少年难治性严重哮喘的诊断和管理(袖珍版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=843a81c001e331cc" title="2019 GINA 全球哮喘处理和预防策略(针对成人和5岁以上儿童)-袖珍指南" target=_blank>2019 GINA 全球哮喘处理和预防策略(针对成人和5岁以上儿童)-袖珍指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=808f01c0016e3823" title="支气管哮喘基层诊疗指南(2018年)" target=_blank>支气管哮喘基层诊疗指南(2018年)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=340d21c001659113" title="特殊健康状态儿童预防接种专家共识之二—支气管哮喘与预防接种" target=_blank>特殊健康状态儿童预防接种专家共识之二—支气管哮喘与预防接种</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0506f1c001639e24" title="2018全球哮喘防治倡议哮喘指南解读" target=_blank>2018全球哮喘防治倡议哮喘指南解读</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%93%AE%E5%96%98" target=_blank>有关哮喘更多指南</a></ul>, tagList=[TagDto(tagId=29513, tagName=过敏性哮喘)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5537, appHits=200, showAppHits=8, pcHits=3702, showPcHits=2526, likes=83, shares=6, comments=4, approvalStatus=1, publishedTime=Thu May 23 00:10:51 CST 2019, publishedTimeString=2019-05-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu May 23 00:10:51 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:16:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 EAACI过敏原免疫治疗指南:家庭尘螨导致的过敏性哮喘)])
2019 EAACI过敏原免疫治疗指南:家庭尘螨导致的过敏性哮喘
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1012537, encodeId=6a9a101253e8b, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa6e5447190, createdName=ms7000002018821778, createdTime=Sun Aug 29 12:19:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964246, encodeId=1db796424639, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a671610372, createdName=Sarinai, createdTime=Mon May 10 11:06:42 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949814, encodeId=035c949814db, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:37:57 CST 2021, time=2021-03-20, status=1, ipAttribution=)]
    2021-08-29 ms7000002018821778

    想看看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1012537, encodeId=6a9a101253e8b, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa6e5447190, createdName=ms7000002018821778, createdTime=Sun Aug 29 12:19:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964246, encodeId=1db796424639, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a671610372, createdName=Sarinai, createdTime=Mon May 10 11:06:42 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949814, encodeId=035c949814db, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:37:57 CST 2021, time=2021-03-20, status=1, ipAttribution=)]
    2021-05-10 Sarinai

    谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1012537, encodeId=6a9a101253e8b, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fa6e5447190, createdName=ms7000002018821778, createdTime=Sun Aug 29 12:19:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964246, encodeId=1db796424639, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a671610372, createdName=Sarinai, createdTime=Mon May 10 11:06:42 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949814, encodeId=035c949814db, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be4f5437570, createdName=ms5000001146316601, createdTime=Sat Mar 20 23:37:57 CST 2021, time=2021-03-20, status=1, ipAttribution=)]
    2021-03-20 ms5000001146316601

    不错

    0